Earningsreport

Q2/2023 6/30/2023 EPS -0.130 ZacksConsensus -0.140 ActVsEst 0.010 - Beat

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx